Lykos Therapeutics

Lykos Therapeutics
Company typePublic benefit corporation
IndustryPharmaceutical; Psychedelic medicine
Founded2014 (2014)
Websitelykospbc.com

Lykos Therapeutics, formerly known as the MAPS Public Benefit Corporation (MAPS PBC), is a public benefit corporation (PBC) developing MDMA ("ecstasy") for potential medicinal use. It was founded and is considerably owned by the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS PBC was founded in 2014 and was renamed to Lykos Therapeutics in January 2024.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.